TY - JOUR
T1 - Relationship Between Cardiac Dysfunction and Cerebral Perfusion in Patients with Aneurysmal Subarachnoid Hemorrhage
AU - Cremers, Charlotte H P
AU - van der Bilt, Ivo A C
AU - van der Schaaf, Irene C.
AU - Vergouwen, Mervyn D I
AU - Dankbaar, Jan Willem
AU - Cramer, Maarten J.
AU - Wilde, Arthur A M
AU - Rinkel, Gabriel J E
AU - Velthuis, Birgitta K.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Introduction: Cardiac dysfunction may occur after aneurysmal subarachnoid hemorrhage (aSAH). Although it is associated with poor outcome, the pathophysiological mechanism of this association remains unclear. We investigated the relationship between cardiac function and cerebral perfusion in patients with aSAH. Methods: We studied 72 aSAH patients admitted within 72 h after ictus with echocardiography and cerebral CT perfusion within 24 h after admission. Cardiac dysfunction was defined as myocardial wall motion abnormalities or positive troponin. In patients with and without cardiac dysfunction, we calculated the mean perfusion [cerebral blood flow (CBF) and time-to-peak (TTP)] in standard regions of interest and calculated differences with 95 % confidence intervals (95 % CI). Results: In 35 patients with cardiac dysfunction minimal CBF was 15.83 mL/100 g/min compared to 18.59 in 37 without (difference of means −2.76; 95 % CI −5.43 to −0.09). Maximal TTP was 26.94 s for patients with and 23.10 s for patients without cardiac dysfunction (difference of means 3.84; 95 % CI 1.63–6.05). Mean global CBF was 21.71 mL/100 g/min for patients with cardiac dysfunction and 24.67 mL/100 g/min for patients without cardiac dysfunction (−2.96; 95 % CI −6.19 to 0.27). Mean global TTP was 25.27 s for patients with cardiac dysfunction and 21.26 for patients without cardiac dysfunction (4.01; 95 % CI 1.95–6.07). Conclusion: aSAH patients with cardiac dysfunction have decreased focal and global cerebral perfusion. Further studies should evaluate whether this relation is explained by a direct effect of cardiac dysfunction on cerebral circulation or by an external determinant, such as a hypercatecholaminergic or hypometabolic state, influencing both cardiac function and cerebral perfusion.
AB - Introduction: Cardiac dysfunction may occur after aneurysmal subarachnoid hemorrhage (aSAH). Although it is associated with poor outcome, the pathophysiological mechanism of this association remains unclear. We investigated the relationship between cardiac function and cerebral perfusion in patients with aSAH. Methods: We studied 72 aSAH patients admitted within 72 h after ictus with echocardiography and cerebral CT perfusion within 24 h after admission. Cardiac dysfunction was defined as myocardial wall motion abnormalities or positive troponin. In patients with and without cardiac dysfunction, we calculated the mean perfusion [cerebral blood flow (CBF) and time-to-peak (TTP)] in standard regions of interest and calculated differences with 95 % confidence intervals (95 % CI). Results: In 35 patients with cardiac dysfunction minimal CBF was 15.83 mL/100 g/min compared to 18.59 in 37 without (difference of means −2.76; 95 % CI −5.43 to −0.09). Maximal TTP was 26.94 s for patients with and 23.10 s for patients without cardiac dysfunction (difference of means 3.84; 95 % CI 1.63–6.05). Mean global CBF was 21.71 mL/100 g/min for patients with cardiac dysfunction and 24.67 mL/100 g/min for patients without cardiac dysfunction (−2.96; 95 % CI −6.19 to 0.27). Mean global TTP was 25.27 s for patients with cardiac dysfunction and 21.26 for patients without cardiac dysfunction (4.01; 95 % CI 1.95–6.07). Conclusion: aSAH patients with cardiac dysfunction have decreased focal and global cerebral perfusion. Further studies should evaluate whether this relation is explained by a direct effect of cardiac dysfunction on cerebral circulation or by an external determinant, such as a hypercatecholaminergic or hypometabolic state, influencing both cardiac function and cerebral perfusion.
KW - Cardiac function
KW - Cerebral perfusion
KW - Subarachnoid hemorrhage
UR - http://www.scopus.com/inward/record.url?scp=84939169851&partnerID=8YFLogxK
U2 - 10.1007/s12028-015-0188-8
DO - 10.1007/s12028-015-0188-8
M3 - Article
C2 - 26264065
AN - SCOPUS:84939169851
SN - 1541-6933
VL - 24
SP - 202
EP - 206
JO - Neurocritical Care
JF - Neurocritical Care
IS - 2
ER -